Global Immunotherapy Market is anticipated to witness a Lucrative CAGR of 13 to 14% by 2027

Cancer Immunotherapy refers to the medical treatment which uses the body’s immune system to fight against the harmful cancer cells. It works by stimulating the immune system to identify and attack the cancer cells. The medical treatment uses substances produced in the body or a laboratory to find cancer cells and fight against these cancer cells. Immunotherapy is used to treat various types of cancer and can be used alone or with chemotherapy.

An increasing cases of cancer, an introduction of new treatment methods such as chimeric antigen receptor (CAR) T-cell therapy, cancer vaccines, adoptive cell transfer (ACT) therapy are some of the leading factors driving the growth of the worldwide immunotherapy market. However, higher costs of immunotherapy and the presence of other affordable treatments such as chemotherapy is projected  to affect the growth of the global immunotherapy market.

Cancer Immunotherapy Market: Emerging Market Trends

Cancer immunotherapy is growing significantly and has been approved for the treatment of many types of cancer. Cancer immunotherapy plays a critical role in the maintenance of the immune system by targeting the infectious agents which may cause cancer through the production of  many antibodies.

Global Immunotherapy Market: Major Growth Drivers

An increasing number of cancer, rising geriatric population, and growing lifestyle changes are some of the prime factors driving the growth of the global immunotherapy market. An increasing number of clinical trials, and growing efficacy and accuracy of the new medical therapies with less or no side effects as compared to the conventional medical treatments such as chemotherapy, are further estimated to drive the immunotherapy market’s growth. Increasing investments by the various government in their research and development activities, and the introduction of new treatment methods such as CART-cell therapy, advanced cancer vaccines, and adoptive cell transfer (ACT) therapy are the other factors driving its growth in the worldwide immunotherapy market.

North America Accounts for the Larger Market Share in the Immunotherapy Market

From a geographic overview, North America accounts for the highest market share in the global immunotherapy market. This can be mainly attributed to the growing number of cancer patients, adoption of immunotherapy across USA oncology practices, fully-developed healthcare infrastructures and the presence of leading market players in North America. 

However, the APAC region is set to witness a consistent growth in the upcoming years in the worldwide immunotherapy market, due to an increasing cases of cancer and the growing population in APAC region.

Competitive Landscape Analysis: Immunotherapy Market

Some of the leading and established players operating in the global immunotherapy market are listed as below: -

  • Amgen Inc.
  • Bayer AG
  • Astellas Pharma Inc.
  • AstraZeneca
  • Bristol-Myers Squibb
  • F. Hoffmann-La Roche
  • Pfizer Inc.
  • Eli Lily and Company
  • Novartis AG
  • Johnson & Johnson
  • Merck and Co. Inc.

The global immunotherapy market is anticipated to gain a consistent momentum in the upcoming years due to the global adoption of new therapeutic treatments and medical therapies, favorable government policies, growing investments in research and development activities, and both organic and inorganic growth strategies adopted by the leading market players in the immunotherapy market during the forecast period.

Get Detailed Insights on Immunotherapy Market Report with a FREE Sample PDF @ https://meditechinsights.com/immunotherapy-market/

Comments

Post a Comment

Popular posts from this blog

Global Healthcare Companion Robots Market valued at about $3 billion (2020), is growing at a lucrative CAGR close to 20% through 2020-2025

Companion robots offer companionship and emotional support for the children, elderly, and disabled people. Over the years, the improvements in sensors, actuators, and AI have led to rise in interest in healthcare companion robots market. Rising aging population, the rising cost of elder care, and shortage of caregivers The population across the globe is aging and the number of caregivers in relation to the aging population is declining. In Japan, there will be an estimated shortage of 1 million caregivers by 2025. Moreover, the cost of elder care is also rising. Between 2019 and 2020, the cost of in-home care jumped by about 4.4%; assisted living costs surged by 6.2%; and nursing home costs increased by 3%. The use of robots instead could help reduce this cost. For instance, a monthly service contract for Stevie (a robot developed by Trinity College, Dublin) would likely run between 50-60% of the cost of hiring a human to do the same tasks, as per their claim. “The growing dispar...
Read more

Global Mycoplasma Testing Market is slated to see a lucrative growth rate of 11% by 2027

Mycoplasmas are the smallest known free-living microorganisms and are frequent contaminants of mammalian cell cultures. For the safety and purity of vaccines and other biological cell-derived products, it is crucial that the cell substrates and unprocessed bulk materials are free of adventitious agents, including mycoplasma.  In many cases, mycoplasmas vary from other forms of bacteria, making them difficult to culture and identify. Testing is done to detect mycoplasma like Mycoplasma hominis, Mycoplasma genitalium, Mycoplasma pneumoniae, and Ureaplasma urealyticum which can cause nongonococcal urethritis (NGU), prostate inflammation (prostatitis), vaginal discharge, and pelvic inflammatory disease (PID) in both men and women. Rising Concerns of Cell Culture Contamination to Trigger the Growth of the Global Mycoplasma Testing Market Mycoplasmas randomly contaminate the fluids used in the bioprocessing and cell culture. It is commonly known that primary cell cultures have a minimum...
Read more

Global Obesity Drugs Market valued at $2.3 billion in 2022, is expected to Witness a Healthy Growth of 25% by 2027

Obesity and overweight are defined as gain of additional fat thus leading to a number of diseases, which can be measured by using body mass index (BMI) as a baseline. A BMI of over 30 is generally considered as obese and a BMI of over 25 is considered as overweight. Obesity is a major risk factor to various diseases such as diabetes, heart diseases, and cancer; approximately over 650 million obese patients living across the world as as projected by World Health Organization (WHO). Rising Obese and Overweight Population to Trigger the Demand of Obesity Drugs Market Obesity is one of the topmost contributors to a number of medical diseases such as heart diseases, stroke, cancer and diabetes. World Obesity Atlas 2022 forecasted the growth of global obese population to be 16.1% in 2025, accounting for 892 million people which will further reach 1,025 million by 2030 with a healthy growth rate of 17.5% in 2030.  Some of the regional obesity burden estimated by World Obesity Atlas 202...
Read more